Patents by Inventor Takashi Sohda

Takashi Sohda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition
    Publication number: 20020002186
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Application
    Filed: July 19, 2001
    Publication date: January 3, 2002
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6329404
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: December 11, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6323225
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: November 27, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6303640
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: October 16, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6288090
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: September 11, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6277869
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: August 21, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6274605
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: August 14, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6271243
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: August 7, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6251924
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in he mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: June 26, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6239153
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: May 29, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6232330
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: May 15, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6225326
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: May 1, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6218409
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: April 17, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Thienodipyridine derivatives, production and use thereof
    Patent number: 6214838
    Abstract: A compound of the formula (I): wherein R is hydrogen or C2-6 alkanoyl; X is halogen; and ring A is benzene ring which is optionally substituted by 1 to 4 substituents selected from {circle around (1)} halogen, {circle around (2)} hydroxy, {circle around (3)} C1-6 alkoxy optionally substituted by halogen or phenyl, {circle around (4)} C1-6 alkylthio optionally substituted by halogen or phenyl, {circle around (5)} C1-6 alkyl optionally substituted by halogen, {circle around (6)} C2-6 alkanoylamino or {circle around (7)} carboxy optionally esterified by C1-6 alkyl, or a salt thereof; which can be used for preventing or treating inflammatory disease, arthritis, chronic rheumatoid arthritis, autoimmune diseases, or rejection after organ transplantation.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: April 10, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Takashi Sohda, Haruhiko Makino, Atsuo Baba, Taihei Yamane
  • Pharmaceutical composition
    Patent number: 6214848
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: April 10, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6211207
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: April 3, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6211206
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: April 3, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6211205
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: April 3, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6174904
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: January 16, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
  • Pharmaceutical composition
    Patent number: 6172090
    Abstract: Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 9, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka